EXLS

41.7201.34%
AF

Andreas Fibig

Independent Director

Mr. Andreas Fibig served as Director of Montai Health, Inc. since May 2023 until August 2026. He has been an Independent Director at ExlService Holdings, Inc. since January 10, 2022. Mr. Fibig served as Director of Novo Nordisk A/S since March 22, 2018 until November 15, 2025. Mr. Fibig has been Director of Indigo Ag, Inc. since 2022. He served as the Chief Executive Officer of International Flavors & Fragrances Inc. (IFF) since September 01, 2014 until February 14, 2022. He served as the Director for Indigo Agriculture Inc. from November 2022 and serves as its Director. He served as Non-Executive Chairman of International Flavors & Fragrances Inc. since December 01, 2014 until 2022 and also served as its Director since March 08, 2011 until 2022. Among the hallmarks of his career are emphases on long-term planning, innovation across all functional areas and the establishment of strong, mutually beneficial Partnerships with customers and stakeholders. He started his career in the health care industry at Schering. He has a record of generating successful results in both highly competitive developed markets and emerging growth markets. He has consistently devoted major investment and interest to people development, making the recognition, reward and promotion of talent a top priority and a critical success factor among his teams. He has extensive expertise in international business, product development and strategic planning. Mr. Fibig has held a number of global positions within the healthcare industry, including Pharmacia GmbH and Boehringer Ingelheim GmbH. He served as President and Country Manager for Pharmacia in Germany, after rising through a series of progressively more senior roles, in Europe and internationally, for Pharmacia, Boehringer Ingelheim and Schering. Mr. Fibig served as Head of the Pharmaceuticals Division at Bayer HealthCare AG since September 1, 2008. He served a number of positions of increasing responsibility at Pfizer Inc., including as Senior Vice President/General Manager in the US Pharmaceutical Operations group from 2007 to 2008, President, Latin America, Africa and Middle East from 2006 to 2007. He serves as the Chairman of the Board of Trustees of the Max Planck Institute for Infection Biology. Mr. Fibig served as the President and Chairman of the Board of Management at Bayer HealthCare Pharmaceuticals Inc., the pharmaceutical division of Bayer AG, from September 2008 to September 2014. He serves as Chairman of German American Chamber of Commerce, Inc. and Chairman and President of 1014 Inc. (Formerly German Academy of New York). He served as an Independent Director of Bunge Limited from August 29, 2016 to May 24, 2018. He serves as Board Member of EFPIA (the European Federation of Pharmaceutical Industries and Associations), Council of the Americas and vfa, the German Association of Research-Based Pharmaceutical Companies. He has been a Member of Advisory Board at RSR Partners, Inc. since June 01, 2017. He holds Degree in Marketing from Berlin School of Economics, Germany in 1982.

Positions